Collegium Pharmaceutical, Inc. (COLL)
48.36
-0.50
(-1.02%)
USD |
NASDAQ |
Dec 11, 16:00
48.35
-0.01
(-0.02%)
After-Hours: 20:00
Collegium Pharmaceutical Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 14.70M |
| Alnylam Pharmaceuticals, Inc. | 1.248B |
| Altimmune, Inc. | 67.72M |
| Vertex Pharmaceuticals, Inc. | 3.954B |
| Viking Therapeutics, Inc. | 222.48M |